Enhancing Immune Response: Clinical Trial of NBS Superfood in COVID-19 Patients

Article Title

The Effects of Nutrition Bio-shield Superfood Powder on Immune System Function: A Clinical Trial Study among Patients with COVID-19

Journal: Frontiers in Immunology

Link: https://doi.org/10.3389/fimmu.2022.919402

Publication Date: August 2022

Corresponding Author: Farid Azizi Jalilian

In the face of infectious pandemics originating from microorganisms, existing treatments often grapple with challenges like drug resistance and evolving pathogens. COVID-19, in particular, has highlighted the limitations of conventional therapies. Antiviral drugs, monoclonal antibodies, and vaccines, while valuable, face hurdles such as uncertain efficacy, variant-specific limitations, and the need for booster shots.

To address these complexities, a patient-centric approach focused on strengthening the immune system emerges as a promising alternative. This strategy proves effective across a spectrum of infectious diseases, irrespective of their origin, offering a more adaptable response to rapidly mutating pathogens. Nutrition Bio-shield Superfood (NBS) stands out as a potential solution, with its immune-boosting properties offering hope in managing various infections.

As we grapple with the WHO's concerns about future pandemics, patient-centered strategies that enhance the immune system's capabilities provide a versatile and resilient approach. NBS superfood, with its ability to empower the body's natural defenses, presents a promising way for combating infectious diseases in our ever-changing microbial landscape.

This study on the effects of NBS superfood was conducted during the peak of the COVID-19 pandemic when the alpha coronavirus strain was predominant. The alpha strain was known for its high transmissibility, posing significant challenges to healthcare providers. Existing treatments had limitations, and there was a need to explore alternative approaches.

In this context, the study investigated the impact of NBS superfood on the immune system and clinical outcomes in COVID-19 patients. The findings suggest that NBS superfood could be a valuable addition to standard treatments, potentially reducing disease severity. This research highlights the importance of considering complementary approaches to manage infectious diseases, especially during pandemics with evolving viral variants.

• Study Design:

Type: Randomized Clinical Trial (RCT)

Participants: COVID-19 patients aged 20 and above.

Groups: Random allocation into two groups: an intervention group receiving standard treatment along with NBS superfood and a control group receiving only standard treatment.

Duration: A 4-week study period to assess the short-term impact of NBS superfood on immune response and clinical markers.

Outcome Measures: Measurement of serum levels of immune system markers (IL-2, IL-6, IL-17, IFNγ, and TNFα) using ELISA technique before and after the intervention. Evaluation of inflammatory markers, tissue protection markers, and clinical outcomes.

• Key Findings:

1. In the intervention group receiving NBS superfood, a significant decrease in serum levels of IL-2, IL-6, and TNF-α was observed after 4 weeks compared to the control group (p < 0.001). These cytokines play a pivotal role in inflammatory responses.

2. NBS superfood demonstrated potential tissue protection, as indicated by a decrease in lactate dehydrogenase (LDH) and creatine phosphokinase (CPK) levels in the intervention group, while levels increased in the control group.

3. White blood cell (WBC) counts and lymphocyte percentages increased significantly in the intervention group, suggesting a balanced and improved immune response.

4. Patients who received NBS superfood experienced shorter hospital stays and lower mortality rates, highlighting its potential to enhance clinical outcomes in COVID-19 patients.

In the midst of the COVID-19 pandemic, inflammation, particularly in the lungs, has emerged as a leading cause of mortality among affected patients. This clinical trial study sought to address this critical issue by evaluating the effects of Nutrition Bio-shield Superfood (NBS) powder on the immune system function and clinical manifestations in COVID-19 patients. The results are noteworthy, as they demonstrate that the addition of NBS to standard treatment significantly reduced the levels of key proinflammatory cytokines, including IL-2, IL-6, and TNF-α. These findings underscore the potential of NBS as an adjunct therapy to standard antiviral treatments, offering promise in the effort to attenuate the inflammatory responses responsible for severe outcomes in COVID-19 patients.

The article underscores the critical role of optimal dietary patterns and sufficient nutrient intake in regulating inflammatory responses and combating oxidative stress during infectious diseases. It highlights that a robust immune response is intricately connected to the consumption of appropriate dietary and nutritional elements, essential for preventing infections.

In this context, NBS emerges as a promising and effective alternative treatment in the fight against COVID-19. NBS, a superfood rich in essential nutrients and plant-based components, aligns with the principles of optimal nutrition. Its unique blend of bioactive compounds can potentially enhance the immune system's resilience against viral infections like COVID-19. By incorporating NBS into the treatment regimen, there's potential to mitigate disease severity and improve patient outcomes, offering a holistic approach to managing infectious diseases during pandemics.